Enable Injections, Inc.

Enable’s strategic partnerships create long-term mutually beneficial relationships with pharmaceutical companies that span clinical development through commercialization. Our partners can differentiate their drug development programs as we expand our enFuse wearable technology to various indications and patient populations who will benefit from our innovative platform. Because of our unique, strategic partnering approach, our business development team has been named a finalist for the 2024 Scrip Awards! Learn more about these prestigious awards here: https://lnkd.in/ev9Kv-5E or contact Matthew Huddleston or Bruce Ernest for more information #ScripAwards #enFuse #drugdelivery #businessdevelopment

We are thrilled for our enFuse Wearable Drug Delivery System to be a finalist for the 2024 Fierce Life Sciences Innovation Awards in the category of Drug Delivery Technology! With entries being judged based on effectiveness, technical innovation, competitive advantage, financial impact, and true innovation, we are honored to be recognized as a finalist! #enFuse #drugdelivery #innovation #FierceInnovationAward

Financial performance is critical when transitioning from a clinical-stage organization to a commercial company. Our CFO Tim Flaherty’s approach has always been grounded in being forward-thinking and solution-oriented, one of the many reasons he was honored as the Cincinnati Business Courier C-Suite Award Winner for Chief Financial Officer. For the past 10 years, Tim has been instrumental in raising millions of dollars of funding, securing key tax incentives, and leading cross-functional teams. We are extremely proud to have such a talented and accomplished individual leading our financial operations, ensuring Enable’s success for years to come! Learn more about Tim here: https://lnkd.in/ggntSZhm

The enFuse Wearable Injector platform is designed with flexibility to meet unique needs of each therapy and use scenario, from a wide range of volumes (5-25mL) to compatibility with various drug product viscosities. Learn more about our innovative drug delivery technology on our new website: https://lnkd.in/gqHkHR-d #enFuse #drugdelivery #innovativetechnology

We’re proud to announce our Business Development team, Matthew Huddleston and Bruce Ernest, has been named as a finalist for the Scrip Awards Business Development Team of the Year! The Scrip Awards recognize the finest innovations and accomplishments in global biopharma, with our team securing multiple shared-value partnerships with leading drug developers to cultivate a growing portfolio that has the potential to impact thousands of patients. Learn more about the award here: https://lnkd.in/ev9Kv-5E #ScripAwards #enFuse #drugdelivery #businessdevelopment

The American Society of Hematology Annual Meeting is only a month away! If you’re attending, stop by Booth 2348 for a live demonstration of our innovative enFuse system or contact us to set up a meeting: https://lnkd.in/eKacC7Xp? ? #ASH24?#DrugDelivery #largevolume #subcutaneousdelivery?#enFuse

Happy Halloween from everyone at Enable Injections! We loved celebrating with our team who is dedicated to making the drug delivery process far less scary. Wishing everyone a safe and happy Halloween! #enFuse #drugdelivery

Thank you to everyone who visited our booth and joined our several presentations at PDA - Parenteral Drug Association Universe of Pre-Filled Syringes and Injections Devices 2024! Between the presentations with our VP of Medical Affairs Mehul Desai, PharmD, MBA and our Tech Talk with Research & Development Director Daniel Waites, our innovative enFuse platform was a popular topic of discussion.?? ? Contact us to learn more about our large-volume, on-body drug delivery solution:?https://lnkd.in/eKacC7Xp???

The recent Drug Development & Delivery special feature focuses on injection devices, including the enFuse wearable drug delivery platform. “The pharma community has made incredible advancements in developing injectable devices that are less painful, ensure precise drug delivery, reduce injection frequency, and integrate with digital health technologies – all of which are important for patients treating chronic diseases.” Read the full edition here: https://lnkd.in/etcZD46g #enFuse #drugdelivery #injectiondevices

We are excited to announce our enFuse Wearable Drug Delivery System is a finalist for Fierce Life Sciences Innovation Awards for Drug Delivery Technology! The enFuse wearable platform is designed to deliver large volumes of medications subcutaneously, in which patients receive their needed treatment in a simple injection under the skin, instead of intravenously. We're proud to be named as a finalist with these other great platforms through Fierce Life Sciences Events, and we look forward to the winner announcement in December! #enFuse #drugdelivery #innovation #FierceInnovationAwards